GenesisM, a joint venture between Bain Capital Real Estate (“Bain Capital”) and Botanic Properties (“Botanic”), announced the official groundbreaking of its 154,000-square-foot Class A biomanufacturing facility at 45 Crosby Drive in Bedford, Massachusetts. The project marks a significant step forward in addressing th…
Varda Space Industries announced a Series C fundraising round today, bringing the total amount of capital raised by the microgravity-enabled life sciences company to $329 million. The $187 million fundraise was led by Natural Capital and Shrug Capital, with participation from Founders Fund, Peter Thiel, Khosla Venture…
BioSpring Builds High-Tech Manufacturing Facility for Pharmaceutical Nucleic Acid APIs Dr. Sylvia Wojczewski, CEO of BioSpring: “With our investment in Offenbach, we are setting new standards in nucleic acid drug substance manufacturing,” explained Wojczewski. “In the future, we’ll be able to produce nucleic acids fo…
As the largest provider of emergency care in Texas, Altus Community Healthcare is recognized for its broad network of freestanding emergency rooms and micro-hospitals that deliver fast, patient-centered care across the state. Known for clinical excellence and community responsiveness, Altus continues to grow—driven by…
Axplora is proud to unveil a transformative €35 million expansion at its Farmabios site in Gropello Cairoli, Italy, reinforcing the company’s longstanding commitment to serving the evolving needs of its customers through strategic investment and innovation. This latest investment builds on the €45 million already comm…
Vetter celebrated the start of construction on its new clinical manufacturing site in the Chicago area with an official groundbreaking ceremony. The state-of-the-art facility, which is being built in Des Plaines, Illinois, is expected to be ready for media fill by the end of 2029. This $285 million investment will str…
WuXi XDC Cayman Inc., a leading global Contract Research, Development and Manufacturing Organization (CRDMO) focused on the bioconjugate industry, announced that the mechanical completion of its manufacturing site at Tuas Biomedical Park in Singapore has been successfully achieved. This milestone signifies that this m…
Sandoz, the global leader in generic and biosimilar medicines, announced the start of construction for a new, state-of-the-art biosimilars production center for sterile product manufacturing in Brnik, Slovenia. This USD 440 million project brings the company’s total planned and ongoing investment in Slovenia to more t…
Alcon, the global leader in eye care dedicated to helping people see brilliantly, announced the official opening of its expanded state-of-the-art manufacturing and logistics facility in Tuas Biomedical Park, Singapore. The event was held in conjunction with the 20th anniversary of Alcon’s operations in Singapore, a me…
Piramal Pharma Solutions, a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma Ltd, recently announced a $90M investment plan to expand two of its U.S. facilities, which are critical to its integrated offering. This ambitious investment underscores the company's commit…
Page 23 of 61